PlainRecalls
FDA Drug Moderate Class II Ongoing

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

Reported: January 1, 2025 Initiated: November 14, 2024 #D-0166-2025

Product Description

UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

Reason for Recall

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.

Details

Recalling Firm
MXBBB
Units Affected
321 bottles
Distribution
Product was sold via Amazon Marketplace.
Location
El Paso, TX

Frequently Asked Questions

What product was recalled?
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323. Recalled by MXBBB. Units affected: 321 bottles.
Why was this product recalled?
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 1, 2025. Severity: Moderate. Recall number: D-0166-2025.